title: Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
abstract: Subjects with impaired fasting glucose (IFG) are at increased risk for type 2 diabetes. We recently demonstrated that IFG subjects have increased hepatic insulin resistance with normal insulin sensitivity in skeletal muscle. In this study, we quantitated the insulin secretion rate from deconvolution analysis of the plasma C-peptide concentration during an oral glucose tolerance test (OGTT) and compared the results in IFG subjects with those in subjects with impaired glucose tolerance (IGT) and normal glucose tolerance (NGT). One hundred and one NGT subjects, 64 subjects with isolated IGT, 24 subjects with isolated IFG, and 48 subjects with combined (IFG + IGT) glucose intolerance (CGI) received an OGTT. Plasma glucose, insulin, and C-peptide concentrations were measured before and every 15 min after glucose ingestion. Insulin secretion rate (ISR) was determined by deconvolution of plasma C-peptide concentration. Inverse of the Matsuda index of whole body insulin sensitivity was used as a measure of insulin resistance; 56 subjects also received a euglycemic hyperinsulinemic clamp. The insulin secretion/insulin resistance (disposition) index was calculated as the ratio between incremental area under the ISR curve (∆ISR[AUC]) to incremental area under the glucose curve (∆G[AUC]) factored by the severity of insulin resistance (measured by Matsuda index during OGTT or glucose disposal during insulin clamp). Compared to NGT, the insulin secretion/insulin resistance index during first 30 min of OGTT was reduced by 47, 49, and 74% in IFG, IGT, and CGI, respectively (all < 0.0001). The insulin secretion/insulin resistance index during the second hour (60-120 min) of the OGTT in subjects with IFG was similar to that in NGT (0.79 ± 0.6 vs. 0.72 ± 0.5, respectively, P = NS), but was profoundly reduced in subjects with IGT and CGI (0.31 ± 0.2 and 0.19 ± 0.11, respectively; P < 0.0001 vs. both NGT and IFG). Early-phase insulin secretion is impaired in both IFG and IGT, while the late-phase insulin secretion is impaired only in subjects with IGT.
authors.affiliation: Diabetes Division, University of Texas Health Science Center, San Antonio, 78229, USA.
authors.forename: Mustafa
authors.initials: M
authors.lastname: Kanat
authors.forename: Luke
authors.initials: L
authors.lastname: Norton
authors.forename: Diedre
authors.initials: D
authors.lastname: Winnier
authors.forename: Chris
authors.initials: C
authors.lastname: Jenkinson
authors.forename: Ralph A
authors.initials: RA
authors.lastname: DeFronzo
authors.forename: Muhammad A
authors.initials: MA
authors.lastname: Abdul-Ghani
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000378:metabolism* / Q000502:physiology; D005215:Fasting / Q000097:blood / Q000378:metabolism* / Q000502:physiology; D005260:Female; D015309:Glucose Clamp Technique; D018149:Glucose Intolerance / Q000097:blood / Q000378:metabolism; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000378:metabolism*; D007333:Insulin Resistance / Q000502:physiology; D000078790:Insulin Secretion; D008297:Male; D053858:Metabolic Networks and Pathways / Q000502:physiology; D008875:Middle Aged; D011236:Prediabetic State / Q000097:blood / Q000378:metabolism; D013997:Time Factors
chemical_list: D001786:Blood Glucose; D007328:Insulin